21232 ⎘
Medicinal preparations containing antigens or antibodies Multivalent vaccine
Multivalent pneumococcal polysaccharide-protein conjugate composition
#602Use of a growth hormone secretagogue peptide as a vaccine adjuvant
#603Methods of manufacturing an immunogenic composition comprising a recombinant protein
#604Norovirus vaccine
#605PCV/mycoplasma hyopneumoniae vaccine
#606Feline calicivirus vaccine
#607Rapid and prolonged immunogic therapeutic
#608Rapid and prolonged immunologic therapeutic
#609Fusion proteins and combination vaccines comprising Protein E and Pilin A
#610Swine influenza a virus vaccine
#611Mycoplasma hyopneumoniae vaccine
#612UspA2 protein constructs and uses thereof
#613Composition comprising iscom particles and live micro-organisms
#614Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigens
#615Methods of vaccine administration
#616Mixed allergen compositions and methods for using the same
#617Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#618Use of the salmonella SPP type III secretion proteins as a protective vaccination
#619Methods for inducing an immune response
#620Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody
#621Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
#622Formulation of a peptide vaccine
#623Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
#624System and method for image generation based on a display-attachable wearable device
#625Method and system for protecting honey bees from pesticides
#626Compositions for booster vaccination against dengue
#627TOXOPLASMA GONDII VACCINES AND THEIR USE
#628Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#629Betacoronavirus mRNA vaccine
#630Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#631Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof
#632Combination immunotherapies for treatment of cancer
#633Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#634MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#635Multivalent feline vaccine
#636Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#637DIFFERENTIAL COATING OF MICROPROJECTIONS AND MICRONEEDLES ON ARRAYS
#638Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof
#639Immunogenic compositions for use in pneumococcal vaccines
#640Multivalent pneumococcal polysaccharide-protein conjugate composition
#641Multivalent pneumococcal polysaccharide-protein conjugate composition
#642Multivalent pneumococcal vaccines
#643Vaccine for protection against ETEC-induced diarrhea comprising dmLT
#644Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
#645Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof
#646Betacoronavirus mRNA vaccine
#647Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#648Alphavirus neoantigen vectors
#649PEPTIDIC CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF
#650Surface display of antigens on Gram-negative outer membrane vesicles
#651UNIVERSAL CANCER VACCINES AND METHODS OF MAKING AND USING SAME
#652Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use
#653Process for preparing pneumococcal polysaccharide-protein conjugates
#654Vaccine and methods for detecting and preventing filariasis
#655Mixed allergen compositions and methods for using the same
#656Compositions and Methods for Generating an Immune Response to LASV
#657Compositions and methods for flavivirus vaccination
#658Pichinde virus reverse genetics systems and methods of use
#659compositions and methods thereof
#660MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#661Vaccine compositions
#662Influenza vaccines with reduced amounts of squalene
#663Methods and compositions for dengue virus serotype 4 epitopes
#664COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY
#665Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestis
#666Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
#667NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES
#668Herpes simplex virus vaccine
#669Immunogenic influenza composition
#670Respiratory syncytial virus vaccine
#671Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#672Polysaccharide and uses thereof
#673composition and methods thereof
#674RECOMBINANT GALLID HERPESVIRUS 3 VACCINES ENCODING HETEROLOGOUS AVIAN PATHOGEN ANTIGENS
#675Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#676Combined vaccine against mycobacterium tuberculosis
#677Saccharide-polypeptide conjugate compositions and methods of use thereof
#678Personalized Site-Specific Immunomodulation
#679Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#680Methods and compositions for live attenuated viruses
#681Sin Nombre virus full-length M segment-based DNA vaccines
#682ExPEC glycoconjugate vaccine formulations
#683MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen
#684Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits
#685Vaccine against necrotic enteritis in poultry
#686Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
#687Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
#688Combination vaccine for swine
#689Methods and compositions for inducing immune responses against Clostridium difficile
#690MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#691Norovirus S particle based vaccines and methods of making and using same
#692IMMUNOGENIC LHRH COMPOSITION AND USE THEREOF IN PIGS
#693Influenza virus mutants and uses therefor
#694IMMUNOGENIC COMPOSITION COMPRISING SURVIVIN PEPTIDES
#695PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE
#696Conjugated vaccine carrier proteins
#697Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
#698Compositions and methods for treating an active infection
#699capsule polysaccharide vaccines
#700Intratumoral vaccination
#701Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#702System and method and device for adjusting image positioning
#703Immunostimulatory preparation exhibiting antitumor activity
#704Virulent vaccines and methods
#705Vaccines against Hepatitis B virus
#706Method for the treatment of patients with carcinomas
#707Food safety vaccine to control and reduce campylobacter in poultry
#708Compositions, methods and therapies for administering antigen peptide
#709IMMUNOGENIC COMPOSITION
#710Fusion proteins and use thereof for preparing vaccines
#711Process for preparing pneumococcal polysaccharide-protein conjugates
#712Influenza vaccine
#713Mixed allergen compositions and methods for using the same
#714Compositions and methods of vaccination against dengue virus in children and young adults
#715Epitope focusing by variable effective antigen surface concentration
#716Mixed allergen compositions and methods for using the same
#717Composition for treating prostate cancer (PCa)
#718PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES
#719Vaccine compositions and methods of use
#720Antigen-adjuvant coupling reagents and methods of use
#721Vaccine for intrauterine disease
#722Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#723Henipavirus vaccine
#724Immunogenic compositions for use in pneumococcal vaccines
#725Universal vaccine platform
#726OmpA and Asp14 in vaccine compositions and as diagnostic targets
#727Tuberculosis compositions and methods of using the same
#728Universal influenza vaccine compositions
#729Universal mammalian influenza vaccine
#730Modified meningococcal FHBP polypeptides
#731Multivalent influenza nanoparticle vaccines
#732Influenza virus hemagglutinin proteins and uses thereof
#733Functional influenza virus like particles (VLPs)
#734Vaccines against infectious diseases caused by positive stranded RNA viruses
#735Vaccines against HPV and HPV-related diseases
#736ADENOVIRUS-VECTORED MULTIVALENT VACCINE
#737Anti-abeta therapeutic vaccines
#738Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
#739Immunogenic composition
#740Combination immunotherapies for treatment of cancer
#741CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
#742Development of a preventive influenza D virus vaccine
#743DIVALENT VACCINE COMPOSITIONS AND THE USE THEREOF FOR TREATING TUMORS
#744Vaccine
#745CHIMERIC DENGUE VIRUS E GLYCOPROTEINS COMPRISING MUTANT DOMAIN I AND DOMAIN II HINGE REGIONS
#746Fusion Comprising A Cell Penetrating Peptide, A Multi Epitope And A TLR Peptide Agonist For Treatment Of Cancer
#747Means and methods for treating HSV
#748Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
#749Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer
#750Compositions and methods for the treatment or prevention of human immunodeficiency virus infection
#751HPIV3 RNA vaccines
#752Vaccine against infectious bronchitis
#753HPV vaccines
#754OmpA in vaccine compositions and as diagnostic targets
#755Formulation of a peptide vaccine
#756Potent and balanced bidirectional promoter
#757Multivalent glycoconjugate vaccines
#758Multivalent glycoconjugate vaccines
#759Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
#760Vaccine comprising drug and parasite administration
#761Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
#762hMPV RNA vaccines
#763POLYVALENT VENOM VACCINES, METHODS OF USE AND MAKING
#764Hepatitis c virus immunogenic compositions and methods of use thereof
#765PCV/vaccine for use with PRRSV vaccine
#766PEPTIDE VACCINES AND DURVALUMAB FOR TREATING BREAST CANCER
#767Optimized HIV envelope gene and expression thereof
#768Influenza peptides and compositions
#769PASSIVE VACCINE FOR ELIMINATION OF SENESCENT CELLS
#770Tetravalent dengue vaccine
#771Vaccines for human papilloma virus and methods for using the same
#772Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#773SALMONELLA VACCINES
#774Periodontitis vaccine and related compositions and methods of use
#775Tumor antigens for determining cancer therapy
#776HER-1, HER-3 and IGF-1R compositions and uses thereof
#777Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
#778Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
#779PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
#780Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza
#781ZIKA VIRUS VACCINE AND COMBINATION VACCINE
#782vaccine
#783Methods to identify prime and boost immunogens for use in a B cell lineage-based vaccination protocol
#784Methods and materials for treating cancer
#785Compositions and methods to treat AIDS
#786Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
#787Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
#788VACCINATION WITH mRNA-CODED ANTIGENS
#789Compositions, methods and uses for dengue virus serotype-4 constructs
#790Adjuvanting meningococcal factor H binding protein
#791Method and system for protecting honey bees from fipronil pesticides
#792Therapeutic HPV vaccine combinations
#793Influenza vaccines
#794Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#795Cancer vaccines
#796RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC
#797vaccine
#798Multigenome retroviral vector preparations and methods and systems for producing and using same
#799L2 peptide immunogenicity
#800Norovirus vaccine formulations
#801COMPOSITIONS AND METHODS FOR TUMOR VACCINATION USING PROSTATE CANCER-ASSOCIATED ANTIGENS
#802Modified biotin-binding protein, fusion proteins thereof and applications
#803MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES
#804Immunogenic compositions comprising
#805Antigen for use in malaria
#806ExPEC glycoconjugate vaccine formulations
#807Multivalent VLP conjugates
#808Influenza virus vaccines and uses thereof
#809Vaccine for intradermal application against PCV2 and PRRS virus infection
#810Artificial invaplex formulated with deacylated lipopolysaccharide
#811Combination vaccine against PCV2 and PRRS virus infection comprising albumin
#812Adhesin tip multiepitope fusion antigen platform and vaccines and their use in the treatment of enterotoxigenic diarrhea
#813Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes
#814Method for producing RNA molecule compositions
#815TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED IMMUNE ACTIVATION
#816STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
#817Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
#818USE OF TNF ALPHA INHIBITOR
#819Multivalent meningococcal polysaccharide-protein conjugate vaccine
#820Mixed allergen compositions and methods for using the same
#821Mixed allergen compositions and methods for using the same
#822Reoviridae vaccine
#823Influenza virus mutants and uses therefor
#824KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#825FORMULATIONS FOR NEOPLASIA VACCINES AND METHODS OF PREPARING THEREOF
#826Gel for treating infectious bronchitis
#827Vaccine and methods for detecting and preventing filariasis
#828Mesenchymal stem cells as vaccine adjuvants and methods for using the same
#829Functional influenza virus-like particles (VLPS)
#830Truncated glycoprotein G of herpes simplex virus 2
#831WT1 antigen peptide conjugate vaccine
#832Polyvalent venom vaccines
#833Immune enhancing recombinant dengue protein
#834Combined enteropathogen recombinant construct
#835POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE
#836Concatemeric peptide epitope RNAs
#837Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
#838Thermally stable rotavirus vaccine formulations and methods of use thereof
#839ATTENUATED MANNHEIMIA HAEMOLYTICA STRAINS
#840capsular polysaccharides and conjugates thereof
#841Immunogenic compositions for use in pneumococcal vaccines
#842ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF
#843Composition comprising iscom particles and live micro-organisms
#844Methods and compositions related to accelerated humoral affinity
#845Bordetella pertussis immunogenic vaccine compositions
#846AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infection
#847Vectors for expression of prostate-associated antigens
#848Mutant fragments of OspA and methods and uses relating thereto
#849Compositions and methods for stabilization of active agents
#850vaccines
#851UspA2 protein constructs and uses thereof
#852Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex
#853Vaccine composition and preparation method and use thereof
#854Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
#855Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
#856Manufacture of vaccines and compositions for the prevention of infections
#857Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using the same
#858INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM
#859Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
#860Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes
#861Oil-in-water emulsion influenza vaccine
#862Methods for the prevention of infections
#863INFLUENZA VIRUS VACCINES AND USES THEREOF
#864Combination PIV3/hMPV RNA vaccines
#865Broad-spectrum vaccine against avian reovirus
#866Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration
#867Vaccine compositions
#868Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof
#869MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#870NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME
#871Compositions and methods for the treatment or prevention of hepatitis B virus infection
#872Microneedle compositions and methods of using same
#873vaccine composition
#874Immunogenic fusion protein
#875Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
#876Multimeric fusion protein vaccine and immunotherapeutic
#877MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#878H7N2 INFLUENZA A VIRUS
#879Vaccine
#880H3 influenza A virus
#881Sexually transmitted disease vaccines
#882Chimeric OspA genes, proteins and methods of use thereof
#883Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells
#884Antimicrobial compositions comprising single domain antibodies and exotoxin
#885Method for improving the efficacy of a survivin vaccine in the treatment of cancer
#886Bivalent swine influenza virus vaccine
#887Vaccine compositions for treatment of Zika virus
#888Stable live attenuated recombinant dengue vaccine
#889Gene optimized Hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
#890Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#891Methods for detection of anti-cytomegalovirus neutralizing antibodies
#892Antigens and vaccines directed against human enteroviruses
#893Nucleic acid derivative having immunostimulatory activity
#894Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, and
#895Live attenuated oral vaccine against shigellosis and typhoid fever
#896OmpA and ASP14 in vaccine compositions and as diagnostic targets
#897IMMUNOGENIC GLYCOPEPTIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#898Methods and compounds for eliminating immune responses to therapeutic agents
#899Multivalent pneumococcal polysaccharide-protein conjugate composition
#900Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species